About | Exhibitors | Speakers | Reviews | Deals |
Average post reach is 127.3k users. Start networking today!
Post
Overview The 6th Annual Precision Medicine Symposium: An Illustrated Tumor Board is a 2-day live conference that will provide expert guidance on how to apply precision medicine approaches into real-world practice for patients with solid tumors and hematologic malignancies. Our expert faculty will review key updates on the latest targeted therapies, with an emphasis on using next-generation sequencing, liquid biopsies, and cytogenetic testing to develop highly individualized treatment plans. This engaging conference will combine highly informative lectures with a variety of interactive sessions.
Listed In
Average post reach is 127.3k users. Start networking today!
Post
Timings09:00 AM-06:00 PM (expected)Not Verified | Entry FeesCheck Official Website |
Estimated Turnout100 - 500 Delegates Based on previous editions | Event TypeConference |
EditionsOct 2024Frequency Not Available | Official LinksWebsiteContacts Report Error Claim this event |
Different Located Editions New York, USA18 - 19 Oct 2024 7 Followers Jersey City, USA20 - 21 Oct 2023 | |
OrganizerQueries about the event?
Ask Organizer
| |
42.367539-71.023157 Venue Map & Directions |
Write a Review
Add Your ReviewHow did you participate in this event?
Followers [ Users who have shown interest for this Event ] Join Community Invite
Add Profile
Invite users with similar interest
Schedule & Agenda
Fri, 18 Oct 08:30 AM - 09:00 AM | Registration and Breakfast | |
Fri, 18 Oct 09:00 AM - 09:10 AM | Welcome and Introductions | |
Fri, 18 Oct 09:10 AM - 10:10 AM | Hot Seat: How Are You Tackling the Logistical Hurdles of Biomarker Testing in Your Clinic? | |
Fri, 18 Oct 10:10 AM - 10:20 AM | Break | |
Fri, 18 Oct 10:20 AM - 10:25 AM | Presession Survey | |
Fri, 18 Oct 10:25 AM - 10:50 AM | Personalizing Treatment With EGFR-Targeted Therapies in Metastatic NSCLC | |
Fri, 18 Oct 10:50 AM - 11:15 AM | What You Need to Know About Emerging Biomarkers in Metastatic NSCLC | |
Fri, 18 Oct 11:15 AM - 11:45 AM | Illustrated Tumor Board: Applying Precision Medicine to Challenging Lung Cancer Cases | |
Fri, 18 Oct 11:45 AM - 12:00 PM | Postsession Survey and Audience Q&A | |
Fri, 18 Oct 12:00 PM - 01:00 PM | Non-CE Product Theater and Lunch | |
Fri, 18 Oct 01:00 PM - 01:05 PM | Introduction of Plenary Presentation Speaker | |
Fri, 18 Oct 01:05 PM - 01:35 PM | Plenary Presentation: Innovations and Ethical Considerations for Artificial Intelligence | |
Fri, 18 Oct 01:35 PM - 01:40 PM | Presession Survey | |
Fri, 18 Oct 01:40 PM - 02:00 PM | Evaluating the Current and Future Role of Minimal Residual Disease Testing in Multiple Myeloma | |
Fri, 18 Oct 02:00 PM - 02:20 PM | Incorporating CAR T-Cell Therapy and Bispecific Antibodies Into the Clinic: Today and Tomorrow | |
Fri, 18 Oct 02:20 PM - 02:40 PM | Medical Crossfire®: Is Transplant Still the Standard of Care in Eligible Patients? | |
Fri, 18 Oct 02:40 PM - 03:00 PM | Postsession Survey and Audience Q&A | |
Fri, 18 Oct 03:00 PM - 03:20 PM | Break | |
Fri, 18 Oct 03:20 PM - 03:25 PM | Presession Survey | |
Fri, 18 Oct 03:25 PM - 03:45 PM | Personalizing Therapy for Early-Stage HR+ Breast Cancer With Genomic Assays | |
Fri, 18 Oct 03:45 PM - 04:05 PM | The Expanding Role of Precision Medicine in HR+ Metastatic Breast Cancer | |
Fri, 18 Oct 04:05 PM - 04:25 PM | Medical Crossfire: Optimizing Antibody-Drug Conjugate Sequencing | |
Fri, 18 Oct 04:25 PM - 07:30 AM | Postsession Survey and Audience Q&A | |
Sat, 19 Oct 07:30 AM - 08:00 AM | Registration and Coffee | |
Sat, 19 Oct 08:00 AM - 08:10 AM | Welcome and Introductions | |
Sat, 19 Oct 08:10 AM - 09:00 AM | How to Manage Your Oncology Practice: Key Insights From Local Leaders | |
Sat, 19 Oct 09:00 AM - 10:00 AM | Non-CE Product Theater and Breakfast | |
Sat, 19 Oct 10:00 AM - 10:15 AM | Break | |
Sat, 19 Oct 10:15 AM - 10:20 AM | Presession Survey | |
Sat, 19 Oct 10:20 AM - 10:50 AM | Managing Aggressive Diffuse Large B-Cell Lymphoma With Novel Therapies | |
Sat, 19 Oct 10:50 AM - 11:10 AM | One Size No Longer Fits All in Mantle Cell Lymphoma MCL | |
Sat, 19 Oct 11:10 AM - 11:40 AM | Illustrated Tumor Board: Applying Precision Medicine to Challenging Lymphoma Cases | |
Sat, 19 Oct 11:40 AM - 11:55 AM | Postsession Survey and Audience Q&A | |
Sat, 19 Oct 11:55 AM - 12:55 PM | Non-CE Product Theater and Lunch | |
Sat, 19 Oct 12:55 PM - 01:00 PM | Presession Survey | |
Sat, 19 Oct 01:00 PM - 01:15 PM | The Emerging Role of PSMA PET Scans in the Evolution of Prostate Cancer Imaging | |
Sat, 19 Oct 01:15 PM - 01:30 PM | How Ongoing Trials of Targeted Therapies and Biomarker-Based Approaches Are Addressing Clinical Gaps | |
Sat, 19 Oct 01:30 PM - 01:45 PM | Incorporating Novel Treatment Approaches Into Existing Paradigms for the Management of Non–Muscle-Invasive | |
Sat, 19 Oct 01:45 PM - 02:00 PM | Postsession Survey and Audience Q&A | |
Sat, 19 Oct 02:00 PM - 02:15 PM | Break | |
Sat, 19 Oct 02:15 PM - 02:20 PM | Presession Survey | |
Sat, 19 Oct 02:20 PM - 02:35 PM | New Targets and New Therapies for Esophagogastric Cancer | |
Sat, 19 Oct 02:35 PM - 02:50 PM | Optimizing Individualized Treatment Plans for Patients With Cholangiocarcinoma | |
Sat, 19 Oct 02:50 PM - 03:10 PM | Medical Crossfire: Precision Medicine in Colorectal Cancer—Is It Ready for Prime Time? | |
Sat, 19 Oct 03:10 PM - 03:25 PM | Postsession Survey and Audience Q&A |
Venue Map & Directions
1 Hotel Dr, Boston, MA 02128
USA
More Events in Boston
Nov 212024 | Boston CyberSecurity Conference Boston, USA |
Dec 122024 | Primary Care Grand Rounds: National Primary Care Policy - Innovation, Financing, and Equity Boston, USA |
Feb 072025 | Annual Business Litigation Conference Boston, USA |
Feb 132025 | BCMP Seminar - Andrew Carter Boston, USA |
Apr 172025 | BCMP Seminar - Jennifer Phillips-Cremins Boston, USA |